Qube Research & Technologies LTD Medicinova Inc Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Medicinova Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,081 shares of MNOV stock, worth $1,513. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,081
Previous 2,714
60.17%
Holding current value
$1,513
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MNOV
# of Institutions
34Shares Held
4.58MCall Options Held
12.5KPut Options Held
1K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.55 Million0.47% of portfolio
-
Black Rock Inc. New York, NY695KShares$973,5870.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$872,6660.0% of portfolio
-
Citigroup Inc448KShares$627,1390.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$613,0040.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $68.7M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...